Lexapro (escitalopram) is one of the most effective medications for anxiety, particularly generalized anxiety disorder (GAD), where it has FDA approval. In clinical trials, 68% of people taking Lexapro for GAD showed a meaningful response after eight weeks, compared to 41% on placebo. That’s a significant gap, and it’s one reason Lexapro is often a first-line prescription for anxiety.
How Lexapro Reduces Anxiety
Lexapro belongs to a class of medications called selective serotonin reuptake inhibitors (SSRIs). It works by blocking the brain’s reabsorption of serotonin, a chemical messenger involved in mood regulation. When serotonin lingers longer between nerve cells instead of being recycled, signaling improves in the circuits that govern worry, fear, and emotional reactivity.
What makes Lexapro stand out among SSRIs is its selectivity. It has very little effect on other brain chemicals like dopamine or norepinephrine, and almost no interaction with histamine or acetylcholine receptors. In practical terms, this means it tends to cause fewer side effects than older antidepressants or less selective SSRIs, which is a real advantage for people already dealing with the physical toll of chronic anxiety.
What the Clinical Evidence Shows
The strongest data for Lexapro and anxiety comes from generalized anxiety disorder trials. In a double-blind, placebo-controlled study, 58% of all patients assigned to Lexapro met the threshold for clinical response (using a stricter analysis that accounts for dropouts), compared to 38% on placebo. Among people who completed the full eight-week trial, that gap widened to 68% versus 41%. These are solid numbers for a psychiatric medication, where placebo response rates tend to run high.
Lexapro is also used for social anxiety disorder, though this is an off-label use. Research on escitalopram for social anxiety has shown that early improvement matters: patients who experienced at least a 10% reduction in social anxiety scores within the first week were roughly seven times more likely to respond well by the end of treatment. This suggests that even small initial shifts can be a meaningful signal that the medication is working for you.
There is also evidence supporting its use in panic disorder, where early improvements in anxiety scores at weeks one through three predicted whether patients would eventually reach remission.
How Long It Takes to Work
This is where patience becomes important. Some people notice subtle improvements in sleep, energy, or appetite within the first one to two weeks. But the full anti-anxiety effect typically takes four to six weeks to develop. That waiting period can feel frustrating, especially when you’re actively anxious, but it reflects how long the brain needs to adapt to sustained changes in serotonin signaling.
If you’re several weeks in and feel nothing at all, that doesn’t necessarily mean the medication has failed. Dose adjustments or a longer trial period may still produce a response. On the other hand, if you notice even modest improvement early on, that’s a genuinely encouraging sign based on the clinical data.
Typical Dosing
The standard starting dose is 10 mg once daily. If needed, this can be increased to 20 mg after at least one week. Most people stay somewhere in the 10 to 20 mg range. The medication is taken at the same time each day, usually in the morning, though some people prefer evening dosing if it causes drowsiness.
Common Side Effects
Side effects are generally mild and most common during the first two weeks. They tend to decrease in both intensity and frequency as your body adjusts, and they rarely cause people to stop taking the medication altogether. The most frequently reported effects include nausea, headache, trouble sleeping or excessive sleepiness, dry mouth, and sexual side effects like decreased libido or difficulty with orgasm. Sexual side effects are the most likely to persist beyond the initial adjustment period.
Because Lexapro has minimal activity on receptors outside the serotonin system, it typically causes less weight gain, sedation, and dry mouth than many older antidepressants. That cleaner side effect profile is a meaningful factor when choosing between medications, since anxiety treatment often continues for months or longer.
Long-Term Use and Maintenance
Many people take Lexapro for well beyond the initial eight-week trial period. For chronic anxiety conditions like GAD, ongoing treatment helps prevent relapse. The FDA notes that long-term efficacy beyond eight weeks hasn’t been formally studied in controlled trials for GAD specifically, so the decision to continue is typically based on individual response. In practice, many clinicians recommend staying on the medication for at least six to twelve months after symptoms improve before considering whether to taper.
What Happens When You Stop
Lexapro should not be stopped abruptly. It has a half-life of about 27 to 32 hours, meaning it clears the body within roughly six days after your last dose. Stopping too quickly can trigger discontinuation symptoms, which are distinct from a relapse of anxiety itself.
These symptoms can include dizziness, nausea, irritability, vivid dreams, a sensation sometimes described as “brain zaps” (brief electric shock-like feelings in the head), and sleep disruption. They’re uncomfortable but not dangerous, and they resolve much faster than an actual anxiety relapse would. One key difference: discontinuation symptoms disappear quickly if you resume the medication, while treating a true relapse takes weeks.
Gradual tapering over two or more weeks significantly reduces the likelihood of these effects. People who stopped rapidly, within one to seven days, were more likely to relapse within a few months than those who tapered gradually. If discontinuation symptoms persist beyond a month and are getting worse rather than better, that may signal a return of the underlying anxiety rather than a withdrawal effect.
How Lexapro Compares to Other Options
Among SSRIs, Lexapro is frequently considered a first choice for anxiety because of its selectivity and tolerability. It achieves its effect with a relatively simple dosing schedule and fewer drug interactions than some alternatives. Benzodiazepines work faster for acute anxiety but carry risks of dependence and cognitive dulling that make them poor long-term solutions. Buspirone is another option for GAD that avoids dependence risk, but it generally produces more modest effects and takes equally long to work.
Therapy, particularly cognitive behavioral therapy, is effective for anxiety on its own and often works best in combination with medication. For moderate to severe anxiety, starting both simultaneously tends to produce better outcomes than either approach alone.